Literature DB >> 33919227

Depression as a Risk Factor for Alzheimer's Disease: A Systematic Review of Longitudinal Meta-Analyses.

Olalla Sáiz-Vázquez1, Patricia Gracia-García2, Silvia Ubillos-Landa3, Alicia Puente-Martínez4, Silvia Casado-Yusta5, Beatriz Olaya6,7, Javier Santabárbara7,8,9.   

Abstract

Alzheimer's disease (AD) is the most frequent cause of dementia, linked to morbidity and mortality among elderly patients. Recently, several clinical studies suggested that depression is a potential risk factor for cognitive decline and AD. A review of meta-analyses was performed, calculating pooled odds ratios to estimate the risk of AD in people with a prior diagnosis (or clinically significant symptoms) of depression. A total of six meta-analyses which represented 28 individual studies were analyzed. A significant association between depression and AD was found (OR = 1.54, 95% CI [1.02-2.31]; p = 0.038). The results showed that heterogeneity across studies was substantial. We found a significant positive effect size for clinical measures of depression, but not for symptomatic rating scales, in the association of depression with risk of AD. The type of rating scale used to assess depression and the cut-off criteria selected also moderated the relationship between depression and AD risk. We found that studies that used clinically significant criteria for diagnosis of depression had more consistent and significant results than studies that used symptomatic scales.

Entities:  

Keywords:  Alzheimer’s disease; clinical and symptomatic criteria; depression; meta-meta-analysis

Year:  2021        PMID: 33919227     DOI: 10.3390/jcm10091809

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  61 in total

1.  The temporal relationship between depressive symptoms and dementia: a community-based prospective study.

Authors:  P Chen; M Ganguli; B H Mulsant; S T DeKosky
Journal:  Arch Gen Psychiatry       Date:  1999-03

2.  Depressive symptoms, sex, and risk for Alzheimer's disease.

Authors:  Gloria Dal Forno; Mark T Palermo; Janet E Donohue; Helen Karagiozis; Alan B Zonderman; Claudia H Kawas
Journal:  Ann Neurol       Date:  2005-03       Impact factor: 10.422

3.  Alzheimer disease and aducanumab: adjusting our approach.

Authors:  Dennis J Selkoe
Journal:  Nat Rev Neurol       Date:  2019-07       Impact factor: 42.937

Review 4.  Depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies.

Authors:  Yuan Gao; Changquan Huang; Kexiang Zhao; Louyan Ma; Xuan Qiu; Lei Zhang; Yun Xiu; Lin Chen; Wei Lu; Chunxia Huang; Yong Tang; Qian Xiao
Journal:  Int J Geriatr Psychiatry       Date:  2012-07-19       Impact factor: 3.485

5.  Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada.

Authors:  S L Tyas; J Manfreda; L A Strain; P R Montgomery
Journal:  Int J Epidemiol       Date:  2001-06       Impact factor: 7.196

6.  Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.

Authors:  Imrich Blasko; Georg Kemmler; Susanne Jungwirth; Ildiko Wichart; Wolfgang Krampla; Silvia Weissgram; Kurt Jellinger; Karl Heinz Tragl; Peter Fischer
Journal:  Am J Geriatr Psychiatry       Date:  2010-11       Impact factor: 4.105

7.  Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons.

Authors:  R S Wilson; J A Schneider; J L Bienias; S E Arnold; D A Evans; D A Bennett
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

8.  A structured interview guide for the Hamilton Depression Rating Scale.

Authors:  J B Williams
Journal:  Arch Gen Psychiatry       Date:  1988-08

9.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.

Authors:  Beverley J Shea; Jeremy M Grimshaw; George A Wells; Maarten Boers; Neil Andersson; Candyce Hamel; Ashley C Porter; Peter Tugwell; David Moher; Lex M Bouter
Journal:  BMC Med Res Methodol       Date:  2007-02-15       Impact factor: 4.615

Review 10.  Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis.

Authors:  Nicolas Cherbuin; Sarang Kim; Kaarin J Anstey
Journal:  BMJ Open       Date:  2015-12-21       Impact factor: 2.692

View more
  8 in total

Review 1.  Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Salomon Poliwoda; Rachel J Kaye; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-07-28

2.  Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-01-30

Review 3.  The enigma of vascular depression in old age: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-15       Impact factor: 3.850

Review 4.  Stress-Induced Depression and Alzheimer's Disease: Focus on Astrocytes.

Authors:  Oleg V Dolotov; Ludmila S Inozemtseva; Nikolay F Myasoedov; Igor A Grivennikov
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

5.  The mediation role of sleep quality in the relationship between cognitive decline and depression.

Authors:  Xiaolei Liu; Xin Xia; Fengjuan Hu; Qiukui Hao; Lisha Hou; Xuelian Sun; Gongchang Zhang; Jirong Yue; Birong Dong
Journal:  BMC Geriatr       Date:  2022-03-03       Impact factor: 3.921

6.  Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways.

Authors:  Masaki Kato; Haruhiko Ogata; Hidetoshi Tahara; Akira Shimamoto; Yoshiteru Takekita; Yosuke Koshikawa; Keiichiro Nishida; Shinpei Nonen; Koichiro Higasa; Toshihiko Kinoshita
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

7.  The association between dietary insulin index and load with mental health.

Authors:  Mina Darand; Ali Amirinejad; Amin Salehi-Abargouei; Ian G Davies; Masoud Mirzaei; Mohsen Mazidi; Sayyed Saeid Khayyatzadeh
Journal:  BMC Psychol       Date:  2022-09-19

8.  Aberrant Structure MRI in Parkinson's Disease and Comorbidity with Depression Based on Multinomial Tensor Regression Analysis.

Authors:  Xuan Cao; Fang Yang; Jingyi Zheng; Xiao Wang; Qingling Huang
Journal:  J Pers Med       Date:  2022-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.